The injectable biologic is directed towards the treatment of chronic viral hepatitis.
China Bio news release, November 1, 2016
Xiamen Amoytop Biotech Co. starts sales of long-acting Paigebin PEGinterferon-2b
The injectable biologic is directed towards the treatment of chronic viral hepatitis.
China Bio news release, November 1, 2016